Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

The Maharashtra Authority for Advance Ruling (AAR) has determined that the cancer prognostic and diagnostic services provided by Epigeneres Biotech Private Limited do not qualify for exemption from ...

An automated solid-phase extraction (SPE) method has been developed to detect cyanotoxins in water. A team of scientists from Friedrich Schiller University Jena and Analytik Jena both in Jena, Germany ...

Therapeutic peptides like semaglutide and tirzepatide, GLP-1 agonists marketed under brand names such ... known as solid-phase peptide synthesis (SPPS) relies on resource-intensive chemical synthesis ...

Sai Life Sciences, a Contract Research, Development, and Manufacturing Organisation (CRDMO), set up a dedicated Peptide Research Center at its integrated R&D Campus here. “As the pharmaceutical ...

The landscape of drug discovery is evolving rapidly, driven by breakthroughs in AI, high-throughput screening and precision medicine. As researchers work to develop safer, more effective therapies, ...

Leveraging genetic recombination technology, research teams have ingeniously fused FGF21 with cell-penetrating peptides (CPPs ... this recombinant FGF21 protein has been shown to simplify purification ...

ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP ... on skin health. GLP-1 receptor agonists are effective at inducing fat loss in patients with obesity and type 2 diabetes, but their ...

ABSTRACT: The increasing use of glucagon-like peptide-1 (GLP ... on skin health. GLP-1 receptor agonists are effective at inducing fat loss in patients with obesity and type 2 diabetes, but their ...